Canada markets closed

Autolus Therapeutics plc (AUTL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.3900+0.3200 (+7.86%)
At close: 04:00PM EDT
4.5000 +0.11 (+2.51%)
After hours: 05:47PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.08B
Enterprise Value 895.72M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)416.93
Price/Book (mrq)9.71
Enterprise Value/Revenue 527.52
Enterprise Value/EBITDA 0.24

Trading Information

Stock Price History

Beta (5Y Monthly) 2.03
52-Week Change 338.44%
S&P500 52-Week Change 326.36%
52 Week High 37.4500
52 Week Low 32.0100
50-Day Moving Average 35.0205
200-Day Moving Average 34.4955

Share Statistics

Avg Vol (3 month) 31.57M
Avg Vol (10 day) 31.52M
Shares Outstanding 5265.93M
Implied Shares Outstanding 6265.93M
Float 8107.56M
% Held by Insiders 118.04%
% Held by Institutions 175.01%
Shares Short (Apr 30, 2024) 43.52M
Short Ratio (Apr 30, 2024) 42.11
Short % of Float (Apr 30, 2024) 41.79%
Short % of Shares Outstanding (Apr 30, 2024) 41.32%
Shares Short (prior month Mar 28, 2024) 44.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-10,337.34%

Management Effectiveness

Return on Assets (ttm)-25.35%
Return on Equity (ttm)-101.61%

Income Statement

Revenue (ttm)1.7M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -168.96M
Net Income Avi to Common (ttm)-208.38M
Diluted EPS (ttm)-1.2000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)239.57M
Total Cash Per Share (mrq)0.9
Total Debt (mrq)223.87M
Total Debt/Equity (mrq)200.82%
Current Ratio (mrq)6.15
Book Value Per Share (mrq)0.64

Cash Flow Statement

Operating Cash Flow (ttm)-145.59M
Levered Free Cash Flow (ttm)-125.13M